Bellus: 4Q Earnings Snapshot

LAVAL, Quebec (AP) _ Bellus Health Inc. (BLU) on Thursday reported a loss of $7.5 million in its fourth quarter.

The Laval, Quebec-based company said it had a loss of 10 cents per share.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 13 cents per share.

The drug developer posted revenue of $4,000 in the period.

For the year, the company reported that its loss widened to $31.8 million, or 54 cents per share. Revenue was nearly unchanged at $15,000.

In the final minutes of trading on Thursday, the company's shares hit $3.92. A year ago, they were trading at $9.27.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on BLU at https://www.zacks.com/ap/BLU